What are the example of orphan drugs?

What are the example of orphan drugs?

An orphan drug can be defined as one that is used to treat an orphan disease. For example, haem arginate, used to treat acute intermittent porphyria, variegate porphyria, and hereditary coproporphyria [12], is an orphan drug.

How do I find out my orphan drug status?

Sponsors seeking orphan drug designation for a drug must submit a request for designation to the agency. Sponsors requesting designation of the same drug for the same rare disease or condition as a previously designated product must submit their own data and information to support their designation request.

What companies have orphan drug status?

Pages in category “Orphan drug companies”

• AbbVie.
• Actelion.
• Alexion Pharmaceuticals.
• Amgen.
• Amicus Therapeutics.
• AstraZeneca.

Is Neulasta an orphan drug?

In fact, 7 of the 10 best-selling drugs of 2015 were also orphan drugs. Included on this list are Rituxan (rituximab), Neulasta (pegfilgrastim), and Revlimid (lenalidomide). The report also states that more than 80 drugs with orphan designation have been approved to treat more than one rare disease.

What is orphan drug in pharmacy?

“Orphan drugs” are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases or disorders that are rare.

How many orphan drugs are there?

In 2020, we continued to see significant progress in the development of treatments for rare diseases, also known as orphan products. Specifically, in 2020, the agency approved 32 novel drugs and biologics with orphan drug designation.

Does orphan drug designation expire?

Orphan Drugs receive a 7-year period of exclusivity from product approval – effective on the date of FDA approval of a marketing application. For seven years, FDA will not approve a subsequent sponsor of the same drug for the same disease (except as otherwise provided).

Is orphan drug Designation good?

Conclusion. The orphan designation appears to be successful at generating positive value for companies, as seen by the positive and significant average increases in stock price.

Is Imbruvica an orphan drug?

Imbruvica was first approved in 2013 in the US and has received orphan drug status in Europe and the US for mantle cell lymphoma, Waldenström macroglobulinemia, and B-cell chronic lymphocytic leukaemia (B-cell CLL).

Is lenalidomide an orphan drug?

During its meeting of 14-16 June 2016, the Committee for Orphan Medicinal Products (COMP) reviewed the designation EU/3/11/924 for Revlimid (lenalidomide) as an orphan medicinal product for the treatment of mantle cell lymphoma.

What is the orphan drug designation list?

It is based upon specific fields captured from the list of orphan drug designations provided by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD). The list posted should be the source used by 340B stakeholders to ensure compliance with the orphan drug exclusion.

What is perifosine used to treat?

Perifosine is an orally active alkyl-phosphocholine compound with potential antineoplastic activity. Targeting cellular membranes, perifosine modulates membrane permeability, membrane lipid composition, phospholipid metabolism, and mitogenic signal transduction, resulting in cell differentiation and inhibition of cell growth.

Is perifosine a phospholipid?

Perifosine is a phospholipid consisting of 1,1-dimethylpiperidinium-4-yl hydrogen phosphate in which the hydrogen is replaced by a stearyl (octadecyl) group. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It is a phospholipid and an ammonium betaine.

What is the difference between perifosine and miltefosine?

Perifosine has a lower gastrointestinal toxicity profile than the related agent miltefosine. (NCI04) Perifosine is a phospholipid consisting of 1,1-dimethylpiperidinium-4-yl hydrogen phosphate in which the hydrogen is replaced by a stearyl (octadecyl) group. It has a role as an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor.